Catalysts for Aurobindo Pharma Ltd
350 tracked
Jan 14, 2026
approval
MYCOPHENOLATE MOFETIL — FDA approval
MYCOPHENOLATE MOFETIL
→
Jan 13, 2026
approval
BENAZEPRIL HYDROCHLORIDE — FDA approval
BENAZEPRIL HYDROCHLORIDE
→
Jan 8, 2026
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Dec 31, 2025
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 29, 2025
approval
PSEUDOEPHEDRINE HYDROCHLORIDE — FDA approval
pseudoephedrine hydrochloride ER
→
Dec 29, 2025
approval
LOPERAMIDE HYDROCHLORIDE — FDA approval
LOPERAMIDE HYDROCHLORIDE
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 23, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 22, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 16, 2025
approval
CARIPRAZINE HYDROCHLORIDE — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Dec 16, 2025
approval
FLUTICASONE PROPIONATE — FDA approval
Fluticasone Propionate Glenmark
→
Dec 15, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 15, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Aurobindo Pharma Ltd
→
Dec 15, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 3, 2025
approval
ERTUGLIFLOZIN — FDA approval
ERTUGLIFLOZIN
→
Nov 28, 2025
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Nov 24, 2025
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Nov 21, 2025
approval
BACLOFEN — FDA approval
BACLOFEN
→
Nov 20, 2025
approval
SERTRALINE HYDROCHLORIDE — FDA approval
SERTRALINE HYDROCHLORIDE
→
Nov 20, 2025
approval
POTASSIUM CHLORIDE — FDA approval
POTASSIUM CHLORIDE
→
Nov 14, 2025
approval
FOSFOMYCIN TROMETHAMINE — FDA approval
FOSFOMYCIN TROMETHAMINE
→
Nov 12, 2025
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Nov 3, 2025
approval
LINAGLIPTIN — FDA approval
LINAGLIPTIN
→
Oct 23, 2025
approval
ONDANSETRON HYDROCHLORIDE — FDA approval
ondansetron hydrochloride CR
→
Oct 23, 2025
approval
OLANZAPINE — FDA approval
olanzapine ODT
→
Oct 7, 2025
approval
TOPIRAMATE — FDA approval
topiramate ER
→